News

According to the company, ViScope is an audio-visual cardiac screening device that enables doctors to visulaize the heart sounds along with hearing them better. ViScope also enables the

In his new role, Mr Bogner will be responsible for Washington health plan operations, as well as the implementation and execution of various strategic initiatives. Mr Bogner replaces

The first Phase II clinical trial, focused on nasolabial folds, was conducted at the Cranley Clinic for Dermatology in London. In this trial six subjects received a low

Rosa of Northern Illinois is a joint venture between Nuclear Oncology Facilities and ASA’s subsidiary, Radiation Oncology Services of America. Rosa of Northern Illinois will own and operate

AstraZeneca had sued Teva Pharmaceutical Industries and Sandoz, alleging infringement of AstraZeneca’s patent as a result of Teva’s and Sandoz’s filings of abbreviated new drug spplications (ANDAs). The

Dr Golumbeski brings to the team nearly 20 years of industry experience serving most recently as vice president of business development, licensing and strategy for the oncology business

The overall results of a Thorough QT (TQT) study designed to demonstrate whether electrocardiographic effects are seen at therapeutic and supra therapeutic doses and conducted under a collaboration

The funding is targeted for the company’s Sepsis study currently underway in Germany. In addition, the funding will allow MedaSorb to support the CE Mark application process and

Ethicon conducted a competitive bidding process to prepare for the divestiture of the Professional Wound Care business, and as a result of such process and receipt of the